Mate, in a former life I was an M&A lawyer, so you can assume I know the difference between MOUs / SPAs / ASAs / CPs / conditions / etc.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling